Doxazosin

Product NDC: 71610-420
11-digit product format: 716100420
Labeler code: 71610
Product ID: 71610-420_70f60997-64ad-4900-aaca-6cc0dbe73def
Type: HUMAN PRESCRIPTION DRUG
Nonproprietary name: Doxazosin Mesylate
Dosage form: TABLET
Route: ORAL
Labeler: Aphena Pharma Solutions - Tennessee, LLC
Application: ANDA209013
Marketing category: ANDA
Marketing start: 2018-04-17
Marketing end: 0000-00-00
Substance: DOXAZOSIN MESYLATE
Active strength: 4 mg/1
Pharmacologic classes: Adrenergic alpha-Antagonists [MoA],alpha-Adrenergic Blocker [EPC]
NDC exclude flag: No
Listing certified through: 2022-12-31
Current FDA listing: Historical FDA.report record

NDC auxiliary status#

These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.

Current NDC status page 1 of 1 · 3 matching rows.

Dataset, Scope, Product NDC table
Dataset	Scope	Product NDC	Package NDC	Code	Status	Source date
excluded product	product	71610-420		I	Inactivated by FDA	2026-08-10
excluded package	package	71610-420	71610-420-09	I	Inactivated by FDA	2026-08-10
excluded package	package	71610-420	71610-420-60	I	Inactivated by FDA	2026-08-10

Observed NDC auxiliary status history#

This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.

Historic NDC status page 1 of 1 · 48 matching rows.

View current auxiliary records. · View the auxiliary file history.

Captured / source date, Dataset, Scope table
Captured / source date	Dataset	Scope	Package NDC	Code	Status	Snapshot	Source SHA-256
2025-12-14 17:58 UTC · source 2025-12-05	excluded product	product		I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71610-420-09	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-12-14 17:58 UTC · source 2025-12-05	excluded package	package	71610-420-60	I	Inactivated by FDA	`d630ba8d3edf…`	`732f749b63fb…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded product	product		I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71610-420-09	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-08-27 00:01 UTC · source 2025-08-26	excluded package	package	71610-420-60	I	Inactivated by FDA	`f5e01cc5f278…`	`a2eaf40c39c3…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded product	product		I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71610-420-09	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-04-01 02:39 UTC · source 2025-03-31	excluded package	package	71610-420-60	I	Inactivated by FDA	`2ef7874e63bc…`	`57b86245f4fa…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded product	product		I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71610-420-09	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-28 20:22 UTC · source 2025-03-28	excluded package	package	71610-420-60	I	Inactivated by FDA	`a1b67e2a42f9…`	`c4cf2c586c0d…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded product	product		I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71610-420-09	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-22 03:12 UTC · source 2025-03-21	excluded package	package	71610-420-60	I	Inactivated by FDA	`cfe11265f3b6…`	`090c488252e2…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded product	product		I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71610-420-09	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-03-10 12:48 UTC · source 2025-03-10	excluded package	package	71610-420-60	I	Inactivated by FDA	`cdf11ea48f46…`	`ba0047e9e063…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded product	product		I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71610-420-09	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-02-02 03:52 UTC · source 2025-01-31	excluded package	package	71610-420-60	I	Inactivated by FDA	`302b2466d912…`	`e7b80fea0513…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded product	product		I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71610-420-09	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-20 13:05 UTC · source 2025-01-20	excluded package	package	71610-420-60	I	Inactivated by FDA	`ed331223b511…`	`672a5bd82f5f…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded product	product		I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71610-420-09	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2025-01-11 03:41 UTC · source 2025-01-10	excluded package	package	71610-420-60	I	Inactivated by FDA	`0efc9e666f02…`	`f202fb6c5f17…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded product	product		I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	71610-420-09	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-11-09 02:27 UTC · source 2024-11-08	excluded package	package	71610-420-60	I	Inactivated by FDA	`ad56d346431e…`	`cc804d4bbf1e…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded product	product		I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	71610-420-09	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-10-04 04:10 UTC · source 2024-10-03	excluded package	package	71610-420-60	I	Inactivated by FDA	`367a005e9d99…`	`383a685ebd0f…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded product	product		I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	71610-420-09	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-07-10 04:00 UTC · source 2024-07-09	excluded package	package	71610-420-60	I	Inactivated by FDA	`557ba5c1ecfa…`	`9c80585c8c6e…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded product	product		I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	71610-420-09	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-28 21:12 UTC · source 2024-05-28	excluded package	package	71610-420-60	I	Inactivated by FDA	`8af77b9d5b6f…`	`d9bbb34c5368…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded product	product		I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	71610-420-09	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-05-15 03:39 UTC · source 2024-05-14	excluded package	package	71610-420-60	I	Inactivated by FDA	`834df4deac94…`	`adcc014656a3…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded product	product		I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	71610-420-09	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2024-03-11 06:39 UTC · source 2024-03-08	excluded package	package	71610-420-60	I	Inactivated by FDA	`1332a3947898…`	`d4bfe170f9cd…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded product	product		E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	71610-420-60	E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`
2022-08-30 03:57 UTC · source 2022-08-29	excluded package	package	71610-420-09	E	Excluded after deficient or non-compliant submission was not corrected	`fb8cb913e6d1…`	`eb8c232b6be0…`

Source provenance: Browse the complete Orange Book source catalog · source snapshot 1.

Orange Book products#

Current product rows page 1 of 1 · 4 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	Approval date
A209013-001	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17
A209013-002	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17
A209013-003	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17
A209013-004	DOXAZOSIN MESYLATE	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 4 matching rows.

Application-product, TE code table
Application-product	TE code
A209013-001	AB
A209013-002	AB
A209013-003	AB
A209013-004	AB

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Product history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209013-001	DOXAZOSIN MESYLATE	EQ 1MG BASE	TABLET / ORAL	AB	2018-04-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209013-002	DOXAZOSIN MESYLATE	EQ 2MG BASE	TABLET / ORAL	AB	2018-04-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209013-003	DOXAZOSIN MESYLATE	EQ 4MG BASE	TABLET / ORAL	AB	2018-04-17	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209013-004	DOXAZOSIN MESYLATE	EQ 8MG BASE	TABLET / ORAL	AB	2018-04-17	`d06236e962d9…`

Observed Orange Book normalized TE history#

Normalized TE history page 1 of 5 · 164 observed states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-02-19 14:30 UTC	2026-02	A209013-001	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209013-002	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209013-003	AB	1	`011fe1cb6892…`
2026-02-19 14:30 UTC	2026-02	A209013-004	AB	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-001	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-002	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-003	AB	1	`31067a03dcf5…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A209013-004	AB	1	`31067a03dcf5…`
2025-08-23 18:47 UTC	2025-08	A209013-001	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209013-002	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209013-003	AB	1	`6a471c1ec25d…`
2025-08-23 18:47 UTC	2025-08	A209013-004	AB	1	`6a471c1ec25d…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-001	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-002	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-003	AB	1	`fd3edfee7708…`
2025-03-22 03:13 UTC · 3 captures of this ZIP	2025-03	A209013-004	AB	1	`fd3edfee7708…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-001	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-002	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-003	AB	1	`b8a1b40f171c…`
2025-02-26 10:13 UTC · 3 captures of this ZIP	2025-02	A209013-004	AB	1	`b8a1b40f171c…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-001	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-002	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-003	AB	1	`03ed91905a0d…`
2025-01-19 17:59 UTC · 7 captures of this ZIP	2025-01	A209013-004	AB	1	`03ed91905a0d…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-001	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-002	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-003	AB	1	`2680178bc6a6…`
2024-12-13 21:23 UTC · 2 captures of this ZIP	2024-12	A209013-004	AB	1	`2680178bc6a6…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-001	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-002	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-003	AB	1	`5bbf6a4d5a75…`
2024-09-14 05:58 UTC · 2 captures of this ZIP	2024-09	A209013-004	AB	1	`5bbf6a4d5a75…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-001	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-002	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-003	AB	1	`d8e5a09893c0…`
2024-11-08 22:44 UTC · 3 captures of this ZIP	2024-11	A209013-004	AB	1	`d8e5a09893c0…`
2024-10-29 15:01 UTC	2024-10	A209013-001	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209013-002	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209013-003	AB	1	`d06236e962d9…`
2024-10-29 15:01 UTC	2024-10	A209013-004	AB	1	`d06236e962d9…`

DailyMed Product Concepts#

Product concept, Relation, Version table
Product concept	Relation	Version	Effective
07a517fc-5845-3816-0f81-0a121804ec9e	Product name	6	20250107
171dd63c-7eea-ede4-c010-4c25ba0a1087	Product name	1	20140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDC	Effective	Action	Document	Indexing SPL	Related label
71610-420-09	2023-01-30	C162847	48780-1	f386c649-bd39-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990
71610-420-60	2023-01-30	C162847	48780-1	f386c649-bd39-0266-e053-dadaa90a7c1a	These highlights do not include all the information needed to use DOXAZOSIN TABLETS safely and effectively. See full prescribing information for DOXAZOSIN TABLETS. DOXAZOSIN tablets, for oral use Initial U.S. Approval: 1990

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDC	Product	Description	Form	Quantity	Strength	SPL version
71610-420-09	Doxazosin	9000 in 1 BOTTLE	TABLET	9000		2
71610-420-60	Doxazosin	90 in 1 BOTTLE	TABLET	90		2

DailyMed Billing Units#

Package NDC, Billing unit, Product NDC table
Package NDC	Billing unit	Product NDC	DailyMed indexing SPL	SPL version	Effective
71610-420-09	EA - Each	71610-420	584c37e4-7486-4ea7-8137-9a2027b912c8	1	2021-08-05
71610-420-60	EA - Each	71610-420	d4b0d3d6-d26e-4698-b9c6-a9ecdccddb70	1	2020-06-05

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDC	Dashboard title	SPL version	Validation	Dashboard ZIP
71610-420	DOXAZOSIN (DOXAZOSIN MESYLATE) TABLET [APHENA PHARMA SOLUTIONS - TENNESSEE, LLC]	2	Legacy NDC, 2 package rows	20210703_5836b416-8a54-4ddd-b574-c2f1b8d480f1.zip

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 6 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Doxazosin	DOXAZOSIN MESYLATE	Bryant Ranch Prepack	277c3278-4fe2-47ac-9115-15b417325ffd	2026-04-13	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209013 application number: ANDA209013
Doxazosin	DOXAZOSIN MESYLATE	Northwind Health Company, LLC	f6c9856e-9154-f349-e053-6294a90a9f2c	2026-01-19	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209013 application number: ANDA209013
Doxazosin	DOXAZOSIN MESYLATE	Upsher-Smith laboratories, LLC	b5d1c604-ce3b-4973-845f-9db267a945cd	2025-11-12	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209013 application number: ANDA209013
Doxazosin	DOXAZOSIN MESYLATE	A-S Medication Solutions	b4c974ad-cbd6-4811-ab48-461e7ffa99f7	2025-09-17	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209013 application number: ANDA209013
Doxazosin	DOXAZOSIN MESYLATE	Aphena Pharma Solutions - Tennessee, LLC	0d9df8e9-f823-4ff8-a5fe-0309dd132b04	2024-02-06	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209013 application number: ANDA209013
Doxazosin	DOXAZOSIN MESYLATE	Aphena Pharma Solutions - Tennessee, LLC	6b74b18f-b89a-4109-a29e-c4fa65a3c5ee	2020-12-10	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 209013 application number: ANDA209013

UNII, Preferred term, Registry number table
UNII	Preferred term	Registry number	Matched term
86P6PQK0MU	DOXAZOSIN MESYLATE	77883-43-3	DOXAZOSIN MESYLATE

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUI	RxNorm string	TTY	DailyMed	SPL version
197627	doxazosin mesylate 4 MG Oral Tablet	PSN	5836b416-8a54-4ddd-b574-c2f1b8d480f1	2
197627	doxazosin 4 MG Oral Tablet	SCD	5836b416-8a54-4ddd-b574-c2f1b8d480f1	2
197627	doxazosin (as doxazosin mesylate) 4 MG Oral Tablet	SY	5836b416-8a54-4ddd-b574-c2f1b8d480f1	2

Packages#

Package NDC, 11-digit format, Description table
Package NDC	11-digit format	Description	Units	Marketing start	Marketing end	Sample	Exclude flag	Status
71610-420-09	71610042009	9000 TABLET in 1 BOTTLE (71610-420-09)	9000 tablet	2021-05-13	0000-00-00	No	No	Current
71610-420-60	71610042060	90 TABLET in 1 BOTTLE (71610-420-60)	90 tablet	2020-04-29	0000-00-00	No	No	Current